课题基金 / 基金详情

Novel Interactive Cell-phone tech for Health Enhancement

Novel Interactive Cell-phone tech for Health Enhancement
用于增强健康的新型互动手机技术
批准号:
6932631
负责人:
Jamie Jackson
金额:
$15.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2006-03-31

项目摘要

项目成果

Jamie Jackson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The burden of chronic disease in the United States is formidable, with 70% of all deaths attributable to some form of chronic illness. As the majority of chronic diseases arise from, and vary in severity with, modifiable behaviors, self-care has enormous potential to ameliorate their course; however, adherence to self-care plans is often poor. Advances in technology can empower patients in novel ways to adhere to self-care management plans. The Palaistra System is a breakthrough wireless remote patient monitoring and response system that collects and transmits patient data and provides daily interactive, individually tailored informative messages, based on patient data, via cellular phones. Adoption and maintenance of recommended lifestyle changes and disease monitoring/management practices are thus facilitated. Proposed, therefore, is Novel Interactive Cell-phone technology for Health Enhancement (NICHE), a controlled clinical trial evaluating the feasibility and efficacy of the Palaistra System in the management of type 2 diabetes in adults. Feasibility outcomes of this Phase I STTR trial are success of implementation in a clinical setting and validated measures of patient and clinician satisfaction. Clinical and disease-specific outcomes include: HbA1c levels, BMI, physical activity levels, diabetes self-care knowledge and self-efficacy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
Physical Activity Lifestyle Intervention for Emerging Adults with Congenital Heart Disease
Self-Management and Transition among Adolescents and Young Adults with Congenital Heart Disease
海外基金